Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1991 Jun;93:175–179. doi: 10.1289/ehp.9193175

Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control.

I B Weinstein
PMCID: PMC1568047  PMID: 1773790

Abstract

There is accumulating evidence that the multistage carcinogenic process is associated with the progressive acquisition of mutations in cellular proto-oncogenes and in growth-suppressor genes. At the same time, several types of evidence indicate that nongenotoxic agents and epigenetic events also play an important role in the evolution of tumors. One of the most intensively studied nongenotoxic agents is the phorbol ester tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and related compounds. Since TPA appears to exert its biologic effects through protein kinase C (PKC), a key enzyme in signal transduction, we have studied this enzyme in considerable detail. Our strategy has been to perturb signal transduction by developing cell lines that overexpress the beta 1 isoform of PKC. Such derivatives of rat fibroblasts display alterations in morphology and growth factors, altered expression of c-myc, ornithine decarboxylase, and phorbin, and increased susceptibility to transformation by certain oncogenes, H-ras, myc, and fos. These findings provide direct genetic evidence that PKC plays a critical role in growth control and the action of certain growth factors, tumor promoters, and oncogenes. In related studies, we have characterized the beta 1 isoform that is overproduced in the above cell systems in terms of its biochemical, kinetic, and immunologic properties. The enzyme has several properties characteristic of native PKCs. A surprising finding is that c-H-ras-transformed derivatives of the cells that overexpress PKC beta 1 display a several-fold increase in the expression of the endogenous alpha 1 isoform of PKC and a decrease in the expression of the endogenous epsilon isoform.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashby J., Tennant R. W. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res. 1988 Jan;204(1):17–115. doi: 10.1016/0165-1218(88)90114-0. [DOI] [PubMed] [Google Scholar]
  2. Fine R. L., Patel J., Chabner B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci U S A. 1988 Jan;85(2):582–586. doi: 10.1073/pnas.85.2.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fitzer C. J., O'Brian C. A., Guillem J. G., Weinstein I. B. The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis. 1987 Feb;8(2):217–220. doi: 10.1093/carcin/8.2.217. [DOI] [PubMed] [Google Scholar]
  4. Friedman E., Isaksson P., Rafter J., Marian B., Winawer S., Newmark H. Fecal diglycerides as selective endogenous mitogens for premalignant and malignant human colonic epithelial cells. Cancer Res. 1989 Feb 1;49(3):544–548. [PubMed] [Google Scholar]
  5. Guillem J. G., Levy M. F., Hsieh L. L., Johnson M. D., LoGerfo P., Forde K. A., Weinstein I. B. Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol Carcinog. 1990;3(2):68–74. doi: 10.1002/mc.2940030204. [DOI] [PubMed] [Google Scholar]
  6. Guillem J. G., O'Brian C. A., Fitzer C. J., Forde K. A., LoGerfo P., Treat M., Weinstein I. B. Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Res. 1987 Apr 15;47(8):2036–2039. [PubMed] [Google Scholar]
  7. Guillem J. G., O'Brian C. A., Fitzer C. J., Johnson M. D., Forde K. A., LoGerfo P., Weinstein I. B. Studies on protein kinase C and colon carcinogenesis. Arch Surg. 1987 Dec;122(12):1475–1478. doi: 10.1001/archsurg.1987.01400240123023. [DOI] [PubMed] [Google Scholar]
  8. Holliday R. DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B Biol Sci. 1990 Jan 30;326(1235):329–338. doi: 10.1098/rstb.1990.0015. [DOI] [PubMed] [Google Scholar]
  9. Housey G. M., Johnson M. D., Hsiao W. L., O'Brian C. A., Murphy J. P., Kirschmeier P., Weinstein I. B. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell. 1988 Feb 12;52(3):343–354. doi: 10.1016/s0092-8674(88)80027-8. [DOI] [PubMed] [Google Scholar]
  10. Housey G. M., O'Brian C. A., Johnson M. D., Kirschmeier P., Weinstein I. B. Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family. Proc Natl Acad Sci U S A. 1987 Feb;84(4):1065–1069. doi: 10.1073/pnas.84.4.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hsiao W. L., Housey G. M., Johnson M. D., Weinstein I. B. Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol Cell Biol. 1989 Jun;9(6):2641–2647. doi: 10.1128/mcb.9.6.2641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hsiao W. L., Wu T., Weinstein I. B. Oncogene-induced transformation of a rat embryo fibroblast cell line is enhanced by tumor promoters. Mol Cell Biol. 1986 Jun;6(6):1943–1950. doi: 10.1128/mcb.6.6.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hsieh L. L., Hoshina S., Weinstein I. B. Phenotypic effects of overexpression of PKC beta 1 in rat liver epithelial cells. J Cell Biochem. 1989 Dec;41(4):179–188. doi: 10.1002/jcb.240410403. [DOI] [PubMed] [Google Scholar]
  14. Kikkawa U., Kishimoto A., Nishizuka Y. The protein kinase C family: heterogeneity and its implications. Annu Rev Biochem. 1989;58:31–44. doi: 10.1146/annurev.bi.58.070189.000335. [DOI] [PubMed] [Google Scholar]
  15. Kirschmeier P. T., Housey G. M., Johnson M. D., Perkins A. S., Weinstein I. B. Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA. 1988 Apr;7(3):219–225. doi: 10.1089/dna.1988.7.219. [DOI] [PubMed] [Google Scholar]
  16. Krauss R. S., Housey G. M., Johnson M. D., Weinstein I. B. Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C. Oncogene. 1989 Aug;4(8):991–998. [PubMed] [Google Scholar]
  17. Makowske M., Ballester R., Cayre Y., Rosen O. M. Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid. J Biol Chem. 1988 Mar 5;263(7):3402–3410. [PubMed] [Google Scholar]
  18. Morotomi M., Guillem J. G., LoGerfo P., Weinstein I. B. Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora. Cancer Res. 1990 Jun 15;50(12):3595–3599. [PubMed] [Google Scholar]
  19. Nair P. P. Role of bile acids and neutral sterols in carcinogenesis. Am J Clin Nutr. 1988 Sep;48(3 Suppl):768–774. doi: 10.1093/ajcn/48.3.768. [DOI] [PubMed] [Google Scholar]
  20. O'Brian C. A., Fan D., Ward N. E., Seid C., Fidler I. J. Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Lett. 1989 Mar 27;246(1-2):78–82. doi: 10.1016/0014-5793(89)80257-1. [DOI] [PubMed] [Google Scholar]
  21. Rotenberg S. A., Krauss R. S., Borner C. M., Weinstein I. B. Characterization of a specific form of protein kinase C overproduced by a C3H 10T1/2 cell line. Biochem J. 1990 Feb 15;266(1):173–178. doi: 10.1042/bj2660173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schaap D., Parker P. J., Bristol A., Kriz R., Knopf J. Unique substrate specificity and regulatory properties of PKC-epsilon: a rationale for diversity. FEBS Lett. 1989 Jan 30;243(2):351–357. doi: 10.1016/0014-5793(89)80160-7. [DOI] [PubMed] [Google Scholar]
  23. Stein B., Rahmsdorf H. J., Steffen A., Litfin M., Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol. 1989 Nov;9(11):5169–5181. doi: 10.1128/mcb.9.11.5169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525–532. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]
  25. Weinberg R. A. Positive and negative controls on cell growth. Biochemistry. 1989 Oct 17;28(21):8263–8269. doi: 10.1021/bi00447a001. [DOI] [PubMed] [Google Scholar]
  26. Weinstein I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res. 1988 Aug 1;48(15):4135–4143. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES